Yavuz Selim Demirel
Overview
Explore the profile of Yavuz Selim Demirel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aydin O, Akbay N, Buyukatalay Z, Arslan F, Dumlupinar E, Celebi Sozener Z, et al.
Allergy Asthma Proc
. 2024 May;
45(3):166-172.
PMID: 38755778
Asthma and chronic obstructive pulmonary disease (COPD) are the most common obstructive diseases. Based on the similarities, we aimed to evaluate sinonasal symptoms in patients with asthma or COPD, and...
2.
Celebi Sozener Z, Ozturk B, Demirel Y, Mungan D
Tuberk Toraks
. 2022 Sep;
70(3):242-251.
PMID: 36164948
Introduction: Asthma and allergic rhinitis frequently coexist and have been regarded as a single airway disease. Clinical features of patients with asthmarhinitis multimorbidity may change depending on the allergic sensitization...
3.
Yildiz R, Demirel Y, Mungan V, Aydin O, Sin B, Agca M, et al.
Tuberk Toraks
. 2022 Sep;
70(3):231-241.
PMID: 36164947
Introduction: To assess the incidence and course of COVID-19 in patients with severe asthma/chronic spontaneous urticaria using biological agents. Materials And Methods: A total of 202 patients (142 with asthma,...
4.
Ozturk B, Yavuz Z, Aydin O, Mungan D, Sin B, Demirel Y, et al.
Int Arch Allergy Immunol
. 2022 Sep;
183(12):1281-1290.
PMID: 36126640
Introduction: Data showing effectiveness of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA) are limited. Methods: This is a single-center retrospective chart review of patients with EGPA treated with...
5.
Erkoc M, Ozturk B, Mungan D, Oztuna D, Bavbek S, Demirel Y, et al.
Asia Pac Allergy
. 2022 Feb;
12(1):e6.
PMID: 35174057
Background: Allergen-specific immunotherapy (AIT) is accepted as the only disease-modifying therapy for IgE-mediated allergic airway diseases and hymenoptera venom allergy. AIT requires repeated contact between patient and physician or nurse...
6.
Ozturk B, Yavuz Z, Eraslan D, Mungan D, Demirel Y, Aydin O, et al.
Int Arch Allergy Immunol
. 2021 Dec;
183(5):526-538.
PMID: 34915496
Background: Mepolizumab has been approved as a treatment option for severe eosinophilic asthma (SEA) patients in our country. We aimed to evaluate the clinical and functional efficacy of mepolizumab in...
7.
Celebi Sozener Z, Mungan D, Aydin O, Secil D, Pinar M, Demirel Y, et al.
Asian Pac J Allergy Immunol
. 2021 Jul;
41(1):20-29.
PMID: 34246220
Background: The clinical and immunological efficacy of preseasonal allergoid immunotherapy has been previously investigated, however, studies comparing the effectiveness of the two protocols are limited in the literature. Objective: The...
8.
Celebi Sozener Z, Ozturk B, Aydin O, Demirel Y, Pinar N, Bavbek S, et al.
Asia Pac Allergy
. 2021 May;
11(2):e16.
PMID: 34007826
Background: This year, pollen season coincided with the first wave of the coronavirus disease 2019 pandemic. Strict preventive measures have been implemented during April and May and then a normalization...
9.
Aydin O, Celebi Sozener Z, Demirel Y, Secil D, Mungan D
Allergy Asthma Proc
. 2021 Jan;
42(1):72-77.
PMID: 33404390
Baker's asthma (BA) is one of the most common causes of occupational asthma. Prevalence of BA varies from 3 to 24% in various studies; however, in our country, there are...
10.
Celebi Sozener Z, Aydin O, Misirligil Z, Mungan D, Demirel Y, Celik G, et al.
J Asthma
. 2017 Aug;
55(7):756-763.
PMID: 28800272
Background: There are limited data regarding the effectiveness of omalizumab in patients with non-allergic asthma. Objective: To evaluate the clinical and functional effectiveness of omalizumab in patients with non-allergic asthma....